Total Payments
$38,820
2024 Payments
$749.98
Companies
18
Transactions
179
Medicare Patients
7,489
Medicare Billing
$512,114
Payment Breakdown by Category
Other$23,122 (59.6%)
Consulting$6,050 (15.6%)
Food & Beverage$5,930 (15.3%)
Travel$3,691 (9.5%)
Education$26.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,122 | 12 | 59.6% |
| Consulting Fee | $6,050 | 2 | 15.6% |
| Food and Beverage | $5,930 | 149 | 15.3% |
| Travel and Lodging | $3,691 | 13 | 9.5% |
| Education | $26.70 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25,208 | 32 | $0 (2024) |
| Amgen Inc. | $8,335 | 29 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,992 | 13 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $461.19 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $439.37 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $434.48 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $376.73 | 11 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $325.53 | 19 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $320.52 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $215.41 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $749.98 | 20 | Amgen Inc. ($254.79) |
| 2023 | $841.65 | 27 | Amgen Inc. ($375.63) |
| 2022 | $887.87 | 21 | Amgen Inc. ($231.20) |
| 2021 | $202.55 | 9 | Merck Sharp & Dohme Corporation ($93.12) |
| 2020 | $485.09 | 13 | AstraZeneca Pharmaceuticals LP ($180.40) |
| 2019 | $501.07 | 17 | Janssen Pharmaceuticals, Inc ($176.97) |
| 2018 | $16,369 | 20 | Novartis Pharmaceuticals Corporation ($8,871) |
| 2017 | $18,782 | 52 | Novartis Pharmaceuticals Corporation ($16,138) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 3 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiology | ||||||
| 08/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.96 | General |
| Category: Cardiovascular | ||||||
| 08/10/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $76.63 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/19/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiology | ||||||
| 06/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Cardiovascular | ||||||
| 06/14/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiology | ||||||
| 06/07/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $104.02 | General |
| Category: Cardiovascular | ||||||
| 05/31/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $114.84 | General |
| Category: Cardiovascular | ||||||
| 04/13/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $99.68 | General |
| Category: Cardiology | ||||||
| 03/29/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiology | ||||||
| 03/24/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $126.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiology | ||||||
| 02/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiology | ||||||
| 01/18/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiology | ||||||
| 01/13/2022 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: Cardiovascular | ||||||
| 11/16/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $66.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Cardiology | ||||||
| 06/07/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Cardiovascular | ||||||
| 05/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,789 | 2,072 | $378,813 | $123,103 |
| 2022 | 24 | 1,886 | 2,228 | $413,566 | $132,815 |
| 2021 | 26 | 1,875 | 2,118 | $387,233 | $133,814 |
| 2020 | 27 | 1,939 | 2,223 | $393,363 | $122,381 |
Total Patients
7,489
Total Services
8,641
Medicare Billing
$512,114
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 5 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 39 | 40 | $14,065 | $3,789 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 42 | 42 | $9,660 | $3,743 | 38.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 24 | 25 | $5,750 | $3,522 | 61.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 41 | 98 | $5,880 | $3,045 | 51.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 32 | 32 | $7,360 | $3,036 | 41.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 39 | 42 | $4,620 | $2,318 | 50.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2020 | 18 | 20 | $13,240 | $1,607 | 12.1% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2020 | 54 | 54 | $4,590 | $1,514 | 33.0% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2020 | 12 | 12 | $3,828 | $965.79 | 25.2% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 12 | 13 | $3,120 | $767.10 | 24.6% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2020 | 65 | 68 | $2,448 | $647.86 | 26.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $1,210 | $622.92 | 51.5% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2020 | 22 | 26 | $2,028 | $529.19 | 26.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 74 | 85 | $2,125 | $521.85 | 24.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 16 | $960.00 | $405.16 | 42.2% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Facility | 2020 | 13 | 13 | $1,066 | $264.49 | 24.8% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 11 | 12 | $960.00 | $246.42 | 25.7% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 14 | 14 | $938.00 | $231.23 | 24.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 17 | $1,190 | $172.79 | 14.5% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Facility | 2020 | 12 | 12 | $984.00 | $160.78 | 16.3% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 14 | 14 | $630.00 | $154.24 | 24.5% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2020 | 12 | 12 | $132.00 | $28.08 | 21.3% |
About Dr. Michael Schoeffler, M.D
Dr. Michael Schoeffler, M.D is a Cardiovascular Disease healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912994880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schoeffler, M.D has received a total of $38,820 in payments from pharmaceutical and medical device companies, with $749.98 received in 2024. These payments were reported across 179 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,122).
As a Medicare-enrolled provider, Schoeffler has provided services to 7,489 Medicare beneficiaries, totaling 8,641 services with total Medicare billing of $512,114. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Oklahoma City, OK
- Active Since 10/05/2005
- Last Updated 06/06/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912994880
Products in Payments
- ENTRESTO (Drug) $22,488
- Repatha (Biological) $8,221
- Resolute (Device) $1,992
- XARELTO (Drug) $461.19
- VERQUVO (Drug) $434.48
- SERELAXIN (Drug) $422.00
- Livalo (Drug) $325.53
- FARXIGA (Drug) $276.15
- ELIQUIS (Drug) $266.90
- PRALUENT ALIROCUMAB INJECTION (Biological) $258.47
- Vascepa (Drug) $215.41
- EVKEEZA (Biological) $191.22
- CAMZYOS (Drug) $172.47
- CARDIOMEMS (Device) $148.19
- LEQVIO (Drug) $126.30
- Zypitamag (Drug) $122.34
- Barostim Neo System (Device) $121.05
- Roszet (Drug) $105.00
- BRILINTA (Drug) $100.58
- NEXLETOL (Drug) $28.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Oklahoma City
Warren Jackman, Md, MD
Cardiovascular Disease — Payments: $2.5M
Cardiovascular Disease $2.5M
George Chrysant, Md, MD
Cardiovascular Disease — Payments: $559,592
Cardiovascular Disease $559,592
Dr. Riaz Sirajuddin, M.d, M.D
Cardiovascular Disease — Payments: $483,835
Cardiovascular Disease $483,835
Sunny Po, Md, MD
Cardiovascular Disease — Payments: $285,383
Cardiovascular Disease $285,383
Dr. John Summers, M.d, M.D
Cardiovascular Disease — Payments: $148,458
Cardiovascular Disease $148,458
Dwight Reynolds, Md, MD
Cardiovascular Disease — Payments: $75,986
Cardiovascular Disease $75,986